Rare diseases
Investigational molecules
Locations
Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels
SpainPhase 2/3 Randomized Study of SKY-0515 for Safety and Efficacy in Adults with Huntington’s Disease
SpainImmune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer
SpainPhase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer
SpainColchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage
SpainA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
SpainEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
SpainStudy of melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)
SpainSafety of autologous NK cells with IL‑15 and CD45RA‑negative T cells with NKG2D CAR in children, adolescents and young adults with high‑grade brain tumors
SpainEfficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study
SpainStudy of REC-4881 in Adults with Familial Adenomatous Polyposis to Assess Safety and Efficacy
SpainStudy of nirmatrelvir and remdesivir to achieve viral clearance in immunocompromised patients with persistent COVID-19
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
